Elizabeth Jinks

Birmingham Research Park — United Kingdom

Medicine · Health Sciences

8h-index498citations20works2.42yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

COVID-19 Clinical Research Studies(10), SARS-CoV-2 and COVID-19 Research(10), Immunotherapy and Immune Responses(3), Immune Cell Function and Interaction(3), Adenosine and Purinergic Signaling(3)

Publications20 total

P2X7R-mediated IL-1β release by human brain tissue: the impact of CNS-penetrant potential therapeutics
Brain·2026Open Access
P2X7R mediated IL-1β release by human brain tissue; impact of CNS-penetrant drugs with potential to treat inflammatory brain disease
University of Birmingham Research Portal (University of Birmingham)·2026
Lag3 and PD-1 pathways preferentially regulate NFAT-dependent TCR signalling programmes during early CD4+ T cell activation
Immunotherapy Advances·2024· 1 citedOpen Access
Salmonella cancer therapy metabolically disrupts tumours at the collateral cost of T cell immunity
EMBO Molecular Medicine·2024· 11 citedOpen Access
Lag3 and PD-1 pathways regulate NFAT-dependent TCR signalling programmes during early CD4 <sup>+</sup> T cell activation
2024Open Access
Regulation of pro‐inflammatory cytokine release by purinergic signalling in a human monocyte‐derived microglial model
Alzheimer s & Dementia·2023· 1 citedOpen Access
A cell-based, SARS-CoV-2 spike protein interaction assay to inform the neutralising capacity of recombinant and patient sera antibodies
Frontiers in Virology·2023Open Access
Mutations in SARS-CoV-2 spike protein impair epitope-specific CD4+ T cell recognition
Nature Immunology·2022· 33 citedOpen Access
A cell-based, spike protein binding assay highlights differences in antibody neutralising capacity for SARS-CoV-2 variants
2022· 1 citedOpen Access
mRNA or ChAd0x1 COVID-19 Vaccination of Adolescents Induces Robust Antibody and Cellular Responses With Continued Recognition of Omicron Following mRNA-1273
Frontiers in Immunology·2022· 5 citedOpen Access
Robust SARS-CoV-2-specific and heterologous immune responses in vaccine-naïve residents of long-term care facilities who survive natural infection
Nature Aging·2022· 7 citedOpen Access
Broad SARS-CoV-2 spike-specific CD4+ T-cell response preserves recognition of variants of concern
2022Open Access
Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection
Nature Immunology·2021· 207 citedOpen Access
mRNA COVID-19 vaccines induce enhanced antibody and cellular responses compared to ChAdOx1 or natural infection in children
2021Open Access
Robust SARS-CoV-2-specific and heterologous immune responses after natural infection in elderly residents of Long-Term Care Facilities
2021Open Access
Children develop robust and sustained cross-reactive spike-specific immune responses following SARS-CoV-2 infection
2021· 10 citedOpen Access
CAR T cells targeting tumor endothelial marker CLEC14A inhibit tumor growth
JCI Insight·2020· 66 citedOpen Access
An evaluation of the tumour endothelial marker <scp>CLEC14A</scp> as a therapeutic target in solid tumours
The Journal of Pathology Clinical Research·2020· 15 citedOpen Access
TEM8/ANTXR1-specific CAR T cells mediate toxicity in vivo
PLoS ONE·2019· 38 citedOpen Access
The human lymph node microenvironment unilaterally regulates T-cell activation and differentiation
PLoS Biology·2018· 103 citedOpen Access

Frequent Co-authors

Paul Moss(8), Alexander C. Dowell(6), Panagiota Sylla(6), Rachel Bruton(6), Eliska Spalkova(6), Jianmin Zuo(5), Neale Harrison(5), Ines Morano(5), Jamie Cowley(5), Hujo Chan(5), Catherine Brady(5), Megan Butler(4), Gokhan Tut(4), Tara Lancaster(4), Jusnara Begum(4), Hayden Pearce(4), Kriti Verma(4), Sandra Margielewska‐Davies(4), Graham S. Taylor(4), Frances Baawuah(4)